No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Endymed Expands Its Operation in North America

Welcomes Bill Scott as Endymed's US Subsidiary President

Editor: What To Know

  • Scott was selected to lead the Company’s operations in the United States and Canada as part of the Company’s growth plan of expanding its operations in North America, and in particular the United States.
  • Bill is motivated to continue the excellence at Endymed and supporting the team in building a world-class sales organization.
  • Most recently, as VP North America Sales at Viora Medical, Bill supported historic revenue growth that followed with an acquisition resulting from success in the U.

Endymed Ltd (TASE: ENDY), currently traded on Tel Aviv Stock Exchange, is pleased to announce the appointment of Bill Scott as President of its US subsidiary, Endymed Inc.

As president of Endymed Inc. Bill will be responsible for leading Endymed’s sales teams in the United States, ensuring customers receive the highest standards of sales and account management support. Mr. Scott was selected to lead the Company’s operations in the United States and Canada as part of the Company’s growth plan of expanding its operations in North America, and in particular the United States. With experience spanning over 25 years in the medical esthetics field, Bill’s leadership and expertise will be invaluable to Endymed’s growth.

A dynamic leader providing support designed for success and growth within the organization. Bill strategically focused on increasing productivity that benefits the bottom-line. Bill possess a deep passion for sales in the aesthetic and surgical arena while developing relationships that promotes long-term progress. While at Palomar Medical, he served as West U.S. and Canada Sales Director. Bill’s team was consistently recognized as the #1 region in sales. In 2013, Bill was recruited as North American VP of Sales at Alma. After rebuilding and stabilizing the sales force, the company attained annual double-digit growth achieving a successful IPO launch in 2017 – more than doubling its valuation. . Most recently, as VP North America Sales at Viora Medical, Bill supported historic revenue growth that followed with an acquisition resulting from success in the U.S. market.

Bill’s proven core competencies include team turnaround leadership focused on sales revenue, sales training, team building & new product launches. Bill is motivated to continue the excellence at Endymed and supporting the team in building a world-class sales organization. The Company believes that the joining of Mr. Scott will drive its US growth plan and help secure a significant reach in the North American market.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy